TABLE 6.
Single and multiple regressions predicting Complex III Activity after controlling for TSI, LOI, or age.
| Complex III Activity r2 (p-value) |
||||||
| Marker | TSI | β (TSI) | LOI | β (LOI) | Age | β (Age) |
| VAT | 0.142 (0.053) | −0.377 | 0.245 (0.009) | −0.495 | ns | −0.315 |
| Testosterone | 0.177 (0.023) | 0.421 | 0.254 (0.005) | 0.504 | 0.269 (0.004) | 0.519 |
| CRP | ns | −0.262 | 0.204 (0.027) | −0.451 | 0.159 (0.053) | −0.399 |
| VAT:total trunk CSA | 0.120 (0.077) | −0.346 | 0.239 (0.010) | −0.488 | ns | −0.321 |
| VAT:TLM | 0.210 (0.016) | −0.459 | 0.283 (0.004) | −0.532 | 0.148 (0.047) | −0.385 |
| VAT + CRP | 0.286 (0.048) | −0.459, −0.238 | 0.371 (0.015) | −0.390, −0.308 | 0.264 (0.063) | −0.289, −0.334 |
| VAT + Testosterone | 0.264 (0.029) | −0.313, 0.355 | 0.392 (0.003) | −0.401, 0.394 | 0.300 (0.016) | −0.220, 0.458 |
| VAT:total trunk CSA + CRP | 0.317 (0.032) | −0.491, −0.305 | 0.379 (0.014) | −0.392, −0.324 | 0.290 (0.046) | −0.326, −0.347 |
| VAT:total trunk CSA + Testosterone | 0.291 (0.019) | −0.348, 0.412 | 0.412 (0.002) | −0.421, 0.422 | 0.326 (0.011) | −0.270, 0.474 |
| VAT:TLM + CRP | 0.316 (0.033) | −0.496, −0.198 | 0.372 (0.015) | −0.405, −0.284 | 0.279 (0.053) | −0.323, −0.304 |
| VAT:TLM + Testosterone | 0.299 (0.017) | −0.375, 0.307 | 0.397 (0.003) | −0.418, 0.357 | 0.313 (0.013) | −0.255, 0.425 |
| IL−6 | ns | −0.396 | ns | −0.269 | 0.195 (0.035) | −0.422 |
| VAT + IL−6 | ns | −0.468, −398 | ns | −0.423, −0.211 | 0.290 (0.054) | −0.312, −0.418 |
Weighted least squares regressions predicting Complex III activity when controlling for TSI, LOI, or age. Non-significant r2 are not shown (non-significant = ns), but non-significant yet trending r2 are included. Standardized Beta weights are presented to demonstrate directionality of associations.
TSI, time since injury; LOI, level of injury; VAT, visceral adipose tissue; CRP, c-reactive protein; IL-6, interleukin 6; LM, lean mass; TLM, total lean mass; CSA, cross sectional area.